Ultrasound could offer affordable, accessible breast cancer screening

November 27, 2012

Ultrasound screening could be a more affordable and convenient way to detect early breast cancers in women, especially for those in countries where there is little access to mammograms, according to University of Pittsburgh School of Medicine research presented today at the annual meeting of the Radiological Society of North America in Chicago. These results are a component of a multinational study that looked at ultrasound as an adjunct to screening mammography.

Researchers, led by Wendie Berg, M.D., Ph.D., professor of radiology at Pitt, and practicing radiologist at Magee-Womens Hospital of UPMC, reviewed data from the Avon Foundation for Women and -sponsored ACRIN 6666 study, which found that the addition of a screening ultrasound or test to annual mammograms was associated with a breast cancer detection benefit for women. Dr. Berg's team evaluated the data from the perspective of using ultrasound as the primary screening method, taking into consideration cancer detection, patient recalls, the number of biopsies performed, and whether those biopsies showed .

"We found that with ultrasound alone compares quite favorably to mammography alone, and was actually better at detecting early invasive breast cancers," said Dr. Berg. "Ultrasound screening could be a viable option, particularly in countries where ultrasound is readily available but access to mammography is limited."

In the ACRIN 6666 study, 2,662 participants enrolled at 21 sites in the U.S., Canada and Argentina completed three annual rounds of mammography screening followed by whole screening, with a 12-month clinical follow-up in the fourth year. Ultrasound screening picked up 53 percent of all breast cancers, as did mammography screening. More importantly, invasive breast cancers constituted the vast majority of cancers detected by ultrasound. Screening ultrasound, however, did result in more false positive results than mammography.

"We designed our study so that women had independent mammograms and screening ultrasound exams," Dr. Berg said. "The primary goal was to examine ultrasound done in addition to mammography but we now have analyzed the data as if ultrasound were the only test performed."

Explore further: Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

Related Stories

Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

April 3, 2012
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident ...

Automated breast ultrasound dramatically reduces physician interpretation time

May 3, 2012
Automated breast ultrasound takes an average three minutes of physician time, allowing for quick and more complete breast cancer screening of asymptomatic women with dense breast tissue, a new study shows.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.